Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Novartis Consumer Health Inc. Stories

2013-04-16 23:00:23

Pharmica Consulting, the life sciences industry leader in leveraging cutting-edge technologies to achieve operational excellence, is pleased to announce that Shrihari Kularni and George Vailakis from Novartis will be speaking at Pharmica´s SharePoint East Conference on May 8-9, 2013 in Princeton, NJ. Princeton, NJ (PRWEB) April 16, 2013 SharePoint has become a recognized investment across the life sciences industry, in which its capabilities have been acknowledged for improving work...

2013-01-31 16:26:24

PARSIPPANY, N.J., Jan. 31, 2013 /PRNewswire/ -- Novartis Consumer Health, Inc. announced today that it is voluntarily recalling certain lots of Triaminic(®) Syrups and Theraflu Warming Relief(®) Syrups that were manufactured in the United States before December 2011. Novartis Consumer Health has decided to issue a voluntary recall to consumers, retail customers and wholesalers in the US because the child-resistant feature of the bottle cap may not function...

2012-01-09 07:30:00

CHADDS FORD, Pa., Jan. 9, 2012 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that, as a result of a temporary shut-down of Novartis Consumer Health Inc.'s Lincoln, Neb., manufacturing facility, there will be a short-term supply constraint of OPANA® ER. The company also announced certain other Endo analgesic products manufactured at this facility may experience short-term supply disruptions. Endo is working closely with the U.S. Food and Drug...

2012-01-08 11:12:00

PARSIPPANY, N.J., Jan. 8, 2012 /PRNewswire/ -- Novartis Consumer Health, Inc. (NCH) announced today that it is voluntarily recalling all lots of select bottle packaging configurations of Excedrin(®) and NoDoz(® )products with expiry dates of December 20, 2014 or earlier as well as Bufferin(®) and Gas-X Prevention(®) products with expiry dates of December 20, 2013 or earlier, in the United States. NCH is taking this action as a precautionary measure because the...

2009-11-12 00:45:00

BASEL, Switzerland, Nov. 12 /PRNewswire/ -- Novartis announced the availability of Prevacid®24HR (lansoprazole delayed-release capsules 15 mg/acid reducer) over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn. Prevacid®24HR received US Food and Drug Administration (FDA) approval in May 2009. It is the first and only over-the-counter (OTC) Proton Pump Inhibitor (PPI) for the treatment of frequent heartburn in its...